Large randomized controlled trials in perioperative cardiovascular medicine: A proposal for the design, conduct and efficient management;Ensaios clínicos aleatórios de larga escala em medicina cardiovascular perioperatória: Uma proposta para delineamento, condução e gerenciamento eficiente

Arquivos Brasileiros de Cardiologia

Volumn 92, Issue 5, 2009, Pages 419-423

  Berwanger, Otavio ^a   Suzumura, Erica Aranha ^a,c   Devereaux, P J ^b  

^a Instituto de Ensino e Pesquisa Hospital Do Coração   (Brazil)

^b MCMASTER UNIVERSITY   (Canada)

^c NONE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ARTERY THROMBOSIS; BRADYCARDIA; CARDIOVASCULAR SYSTEM; CLINICAL TRIAL; HUMAN; HYPOTENSION; MEDICAL PRACTICE; MEDICAL PROFESSION; MORTALITY; PERIOPERATIVE PERIOD; REVIEW; CARDIOVASCULAR DISEASE; METHODOLOGY; PEROPERATIVE COMPLICATION; RANDOMIZED CONTROLLED TRIAL; STANDARD;

CARDIOVASCULAR DISEASES; HUMANS; INTRAOPERATIVE COMPLICATIONS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 67449101554     PISSN: 0066782X     EISSN: 16784170     Source Type: Journal    
DOI: None     Document Type: Review

References (31)

1. Lee TH, Marcantonio ER, Mangione CM, Thomas EJ, Polanczyk CA, Cook F, et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation. 1999; 100: 1043-9. (Pubitemid 29416229)
2. Devereaux PJ, Goldman L, Cook DJ, Gilbert K, Leslie K, Guyatt GH. Perioperative cardiac events in patients undergoing noncardiac surgery: a review of the magnitude of the problem, the pathophysiology of the events and methods to estimate and communicate risk. CMAJ. 2005; 173 (6): 627-634 (Pubitemid 41345578)
3. Mangano D. Perioperative cardiovascular morbidity: new developments. Ballieres Clin Anaesthesiol. 1999; 13 (3): 335-348
4. Cook DJ, Mulrow CD, Haynes RB. Systematic reviews: synthesis of best evidence for clinical decisions. Ann Intern Med. 1997; 126 (5): 376-380 (Pubitemid 27102522)
5. Moher D, Cook DJ, Jadad AR, Tugwell P, Moher M, Jones A, et al. Assessing the quality of reports of randomised trials: implications for the conduct of meta-analyses. Health Technol Assess. 1999; 3 (12): i-iv, 1-98. (Pubitemid 29270516)
6. Juni P, Altman DG, Egger M. Systematic reviews in health care: assessing the quality of controlled clinical trials. BMJ. 2001 ; 323 (7303): 42-46 (Pubitemid 32682008)
7. Warlow C. How to do it: organise a multicentre trial. BMJ. 1990; 300: 180-183
8. Day SJ, Altman DC. Blinding in clinical trials and other studies. BMJ. 2000; 321: 504. (Pubitemid 30623610)
9. Schulz KF, Grimes DA. Blinding in randomised trials: hiding who got what. Lancet. 2002; 359: 696-700. (Pubitemid 34203775)
10. Montori VM, Devereaux PJ, Adhikari NK, Burns KE, Eggert CH, Briel M, et al. Randomized trials stopped early for benefit: a systematic review. JAMA. 2005; 294 (17): 2203-2209
11. Chen ZM. Organizing large randomized trials in China: opportunities and challenges. Drug Inf J. 1998; 32: 1193S-1200S.
12. Rosenfeld BA, Beattie C, Christopherson R, Norris EJ, Frank SM, Breslow MJ, et al. The effects of different anesthetic regimens on fibrinolysis and the development of postoperative arterial thrombosis. Perioperative Ischemia Randomized Anesthesia Trial Study Group. Anesthesiology. 1993; 79 (3): 435-443
13. Schug SA, Torrie JJ. Safety assessmentof postoperative pain management by an acute pain service. Pain. 1993; 55 (3): 387-391 (Pubitemid 23350586)
14. Frank SM, Beattie C, Christopherson R, Norris EJ, Perler BA, Williams GM, et al. Unintentional hypothermia is associated with postoperative myocardial ischemia: the Perioperative Ischemia Randomized Anesthesia Trial Study Group. Anesthesiology. 1993; 78 (3): 468-476
15. Nelson AH, Fleisher LA, Rosenbaum SH. Relationship between postoperative anemia and cardiac morbidity in high-risk vascular patients in the intensive care unit. Crit Care Med. 1993; 21 (6): 860-866 (Pubitemid 23173023)
16. Sametz W, Metzler H, Gries M, Porta S, Sadjak A, Supanz S, et al. Perioperative catecholamine changes in cardiac risk patients. Eur J Clin Invest 1999; 29 (7): 582-587 (Pubitemid 29322369)
17. Shoemaker WC, Appel PL, Kram HB. Tissue oxygen debt as a determinant of lethal and nonlethal postoperative organ failure. Crit Care Med. 1988; 16 (11): 1117-1120 (Pubitemid 18267294)
18. Mahla E, Tiesenhausen K, Rehak P, Fruhwald S, Purstner P, Metzler H. Perioperative myocardial cell injury: the relationship between troponin T and cortisol. J Clin Anesth. 2000; 12 (3): 208-212 (Pubitemid 30408519)
19. Dawood MM, Gutpa DK, Southern J, Walia A, Atkinson JB, Eagle KA. Pathology of fatal perioperative myocardial infarction: implications regarding pathophysiology and prevention. Int J Cardiol. 1996; 57 (1): 37-44. (Pubitemid 26388825)
20. Priebe HJ. Triggers of perioperative myocardial ischaemia and infarction. Br J Anaesth. 2004; 93(1): 9-20. (Pubitemid 38967425)
21. POISE Trial Investigators, Devereaux PJ, Yang H, Guyatt GH, Leslie K, Villar JC. Rationale, design, and organization of the Perioperative ischemic Evaluation (POISE) trial: a randomized controlled trial of metoprolol versus placebo in patients undergoing noncardiacsurgery. Am Heart J. 2006; 152 (2): 223-230 (Pubitemid 44093413)
22. Juul AB, Wetterslev J, Kofoed-Enevoldsen A, Callesen T, Jensen G, Gluud C. Diabetic postoperative mortality and morbidity group. The Diabetic Postoperative Mortality and Morbidity (DIPOM) trial: rationale and design of a multicenter, randomized, placebo-controlled, clinical trial of metoprolol for patients with diabetes mellitus whoare undergoing major noncardiac surgery. Am Heart J. 2004; 147 (4): 677-683
23. Flood C, Fleisher LA. Preparation of the cardiac patient for noncardiac surgery. Am Fam Physician. 2007; 75 (5): 656-665
24. Reich DL, Fischer GW. Perioperative interventions to modify risk of morbidity and mortality. Semin Cardiothorac Vasc Anesth. 2007; 11 (3): 224-230 (Pubitemid 47301106)
25. Fleming TR, DeMets DL. Surrogate end points in clinical trials: are we being misled? Ann Intern Med. 1996; 125 (7): 605-613
26. Wittes J, Lakatos E, Probstfield J. Surrogate endpoints in clinical trials: cardiovascular diseases. Stat Med. 1989; 8 (4): 415-425 (Pubitemid 19105889)
27. Pete R, Baigent C. Trials: the next 50 years. Large scale randomised evidence of moderate benefits. BMJ. 1998; 317: 1170-1171
28. Collins R, Peto R, MacMahon S, Hebert R Fiebach NH, Eberlein KA, et al. Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet. 1990; 335: 827-838
29. Yusuf S, Pete R, Lewis J, Collins R, Sleight P. Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis. 1985; 27 (5): 335-371 (Pubitemid 15107153)
30. Farrell B. Efficient management of randomised controlled trials: nature or nurture. BMJ. 1998; 317: 1236-1239 (Pubitemid 28488519)
31. Eisenstein EL, Lemons PW 2nd, Tardiff BE, Schulman KA, Jolly MK, Califf RM. Reducing the costs of phase III cardiovascular clinical trials. Am Heart J. 2005; 149 (3): 482-488